
Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate
Keywords: Acne; Skin; Oral contraceptives; Dienogest; Cyproterone acetate; Valette; Diane 35; Randomized clinical trial